
Written by:

Medically Reviewed by:
Last Updated:
April 21st, 2026
Codeine addiction
Codeine addiction is one of the most common forms of opioid dependence in the UK. But because it’s found in everyday medicines like Nurofen Plus and Solpadeine, and regularly prescribed for pain, it carries a false sense of safety and is often overlooked.
In reality, codeine is an opioid, affecting the brain in much the same way as stronger drugs like morphine. Dependence often develops quietly, starting with genuine pain relief but gradually taking the user towards addiction.
Understanding how codeine addiction happens is the first step toward taking back control.
What is Codeine?
Codeine is a naturally occurring opioid analgesic belonging to the phenanthrene alkaloid family, derived directly from the opium poppy plant (Papaver somniferum). It was first isolated in 1832 and has been used medicinally for nearly two centuries, primarily as a pain reliever and cough suppressant. It remains one of the most prescribed and most consumed opioids in the world.
In the UK, codeine occupies a unique and clinically significant position: it is the only opioid analgesic available for purchase without a prescription, in low-dose combination products, from community pharmacies. This over-the-counter availability and its association with branded, everyday medications contributes substantially to the underestimation of its addiction potential by both the public and some healthcare professionals.
How Codeine is Classified and Dispensed
Codeine is classified as a Schedule 5 controlled drug in the UK when present in low-dose combination products. In this form, it can be sold over the counter by a pharmacist without a prescription, subject to a sale limit of one pack per transaction.
At higher doses and in single-ingredient preparations, codeine requires a prescription and is classified as a Schedule 2 controlled drug, the same category as morphine and oxycodone. Commonly prescribed codeine formulations include:
- Codeine phosphate tablets (15mg, 30mg, 60mg), prescribed for mild to moderate pain
- Codeine linctus, a liquid preparation historically prescribed as a cough suppressant
- Co-codamol, a combination of codeine and paracetamol, available over the counter (8/500mg) and by prescription (15/500mg, 30/500mg)
- Codeine with ibuprofen available over the counter as products such as Nurofen Plus (12.8mg codeine per tablet)
- Co-dydramol, a combination of codeine with dihydrocodeine, prescribed for pain
The widespread availability of over-the-counter codeine, embedded in products that many people associate with ordinary headache or cold relief rather than opioid drugs, is a defining feature of codeine addiction that sets it apart from other opioid use disorders and requires specific clinical attention.
Codeine-Containing Products and Over-the-Counter Access
The following commonly available over-the-counter products contain codeine and are a significant source of codeine misuse:
- Nurofen Plus: Ibuprofen 200mg and codeine phosphate 12.8mg per tablet; one of the most commonly misused OTC codeine products in the UK
- Solpadeine Max, Plus, and Solpadeine Headache: Paracetamol with codeine 12.8mg per tablet, in various formulations
- Panadol Ultra: Paracetamol and codeine 12.8mg per tablet
- Migraleve: Paracetamol, codeine 8mg, and buclizine (an antihistamine); marketed for migraine
- Kaolin and Morphine Mixture: Contains a small amount of morphine (not codeine) but relevant as a related OTC opioid-containing preparation
Because these products are sold in pharmacies alongside vitamins and cold remedies, and because they carry familiar brand names rather than the word “opioid”, many people who develop dependence on them do not initially recognise what they are dependent on. People regularly present to addiction services having taken large quantities of these products daily for months or years before understanding that the substance driving their dependence is an opioid.
Codeine as a Prodrug and Its Connection to Morphine
A critical and frequently misunderstood aspect of codeine’s pharmacology is that codeine itself is largely inactive as an opioid. It is a prodrug, a compound that must be metabolised by the body into an active form before it exerts its pharmacological effect.
Codeine is converted to morphine in the liver by the enzyme CYP2D6, a member of the cytochrome P450 enzyme family. It is this morphine, produced inside the body from the codeine taken, that crosses the blood-brain barrier, binds to mu-opioid receptors, and produces codeine’s analgesic and euphoric effects. In this respect, taking codeine is, neurobiologically, equivalent to taking a lower dose of morphine.
This prodrug mechanism has two important clinical implications:
- Genetic variability (CYP2D6): People process codeine differently. Some convert it into morphine far more quickly, leading to stronger effects and a higher risk of toxicity.
- Opioid-based addiction: Codeine is converted into morphine, meaning its addiction, dependence, and withdrawal are the same as other opioids
How the Brain Changes with Regular Codeine Use
With repeated codeine use, the brain undergoes the same progressive neuroadaptive changes that occur with any opioid and adaptations designed to restore equilibrium but that result in tolerance, physical dependence, and ultimately the compulsive use that defines addiction.
Patterns of Over-the-Counter Codeine Misuse
Over-the-counter codeine misuse follows patterns that are distinct from illicit opioid use and that reflect the particular pharmacology and availability of these products:
- Pharmacy hopping: Visiting multiple pharmacies across a day or week to circumvent the one-pack-per-transaction limit, sometimes travelling significant distances and visiting many different establishments
- High-dose consumption: Taking very large numbers of tablets daily in order to achieve a meaningful codeine dose once tolerance has developed. At these quantities, the co-formulated paracetamol or ibuprofen becomes a serious toxicological concern in its own right
- Concealment and shame: Stockpiling tablets, hiding packaging, and being acutely secretive about use. Many OTC codeine-dependent individuals experience profound shame about their habit and delay seeking help for years as a result
- Functional dependence: Maintaining employment, relationships, and outward appearances while dependent, making the problem invisible to those around them and sometimes to themselves
What Codeine Does to the Body
Codeine affects the body in two overlapping ways: through its conversion into an opioid in the brain, and through the cumulative strain caused by the other painkillers it is often combined with in over-the-counter medications. Over time, this combination can impact multiple organ systems, particularly with repeated or high-dose use.
The Gastrointestinal System
Opioid receptors are densely distributed throughout the gastrointestinal tract, and codeine’s effects on the gut are among its most consistent and burdensome physical consequences:
- Severe, chronic constipation is a near-universal feature of regular codeine use, caused by profound slowing of gastrointestinal motility. Unlike many of codeine’s effects, tolerance to constipation does not develop reliably, meaning that even long-term users continue to experience significant bowel disruption.
- Prolonged constipation causes haemorrhoids, anal fissures, faecal impaction, and in extreme cases bowel obstruction, complications that frequently require medical intervention.
- Nausea, abdominal bloating, and gastric discomfort are common and can be severe, particularly during dose escalation or in combination with high-dose ibuprofen’s gastropathic effects.
- In OTC codeine misuse involving ibuprofen-combination products, the NSAID-mediated gastric damage compounds the opioid’s gastrointestinal effects, increasing the risk of peptic ulcer disease and upper gastrointestinal bleeding.
The Liver
The liver bears a disproportionate burden in OTC codeine misuse, primarily through paracetamol co-ingestion:
- Regular consumption of paracetamol above the therapeutic threshold causes cumulative hepatocellular damage, progressing through hepatic inflammation to fibrosis and, in severe cases, cirrhosis and liver failure.
- The risk is substantially elevated in those who consume alcohol regularly, a common co-occurrence in codeine dependence, as alcohol induces CYP2E1, increasing the production of the hepatotoxic paracetamol metabolite NAPQI.
- Codeine is itself metabolised by the liver, and its active metabolite glucuronide conjugates are hepatically processed. In individuals with pre-existing liver disease, codeine metabolism is impaired, leading to drug accumulation and elevated risk of toxicity.
The Kidneys
- Chronic high-dose ibuprofen use carries a significant risk of progressive renal impairment, including analgesic nephropathy and chronic kidney disease.
- Opioid-induced dehydration from vomiting and constipation-related fluid imbalance further compromises renal perfusion, compounding NSAID-related kidney stress.
The Respiratory System
- Like all opioids, codeine suppresses the brain stem’s respiratory control centres, slowing the rate and depth of breathing. At therapeutic doses this is generally mild, but at high doses respiratory depression can be life-threatening.
- There have been documented fatalities in children prescribed codeine following tonsillectomy who were ultra-rapid metabolisers.
The Endocrine System
- Chronic codeine use disrupts the hypothalamic-pituitary axis, suppressing gonadotropin-releasing hormone and downstream sex hormones. In men this produces reduced libido, erectile dysfunction, and fatigue; in women it may cause menstrual irregularities, reduced fertility, and mood disturbance.
- Long-term opioid exposure is associated with reduced bone density through hormonal suppression and direct effects on bone remodelling, increasing fracture risk with prolonged use.
- The HPA stress axis is chronically dysregulated, contributing to the heightened anxiety and stress intolerance that characterise established codeine dependence.
The Central Nervous System
- Persistent cognitive impairment, including difficulties with memory, concentration, and information processing, is a recognised consequence of chronic opioid use and reflects the functional suppression of cortical activity by mu-receptor activation.
- Opioid-induced sleep architecture disruption is common in long-term codeine users. Codeine suppresses REM sleep, reducing sleep quality even when sleep duration appears normal. Rebound REM sleep following cessation, characterised by vivid, often disturbing dreams, is a consistent feature of codeine withdrawal.
- Medication overuse headache (MOH) is a clinically important and common consequence of regular codeine use for headache. Opioids paradoxically lower the pain threshold with chronic use, causing more frequent and more severe headaches that then drive further codeine consumption. MOH affects a significant proportion of people who use codeine-containing products regularly for headache management.
Signs and Symptoms of Codeine Addiction
Recognising codeine addiction is complicated by the drug’s legal status, its medical framing, and its integration into ordinary daily routines. The signs span psychological, behavioural, and physical domains and are frequently attributed to other causes before codeine is identified as the problem.
- Taking codeine beyond the stated reason: Using codeine not just for pain but to manage anxiety, stress, low mood, boredom, or emotional discomfort; using it as an emotional crutch rather than a targeted pain reliever
- Inability to reduce or stop despite wanting to: Repeated genuine attempts to cut down or quit that fail, often due to withdrawal symptoms being interpreted as a return of original pain or new illness
- Pharmacy hopping and supply-seeking behaviour: Visiting multiple pharmacies, online sources, or using multiple prescriptions to maintain supply beyond what a single source provides
- Preoccupation with having enough: Anxiety about running out; keeping stockpiles; planning activities around access to codeine; feeling unable to travel or function without an adequate supply
- Concealment and shame: Hiding packaging, disposing of boxes discreetly, denying or minimising use when asked by family members or healthcare providers
- Continuing use despite recognised harm: Being aware that codeine is causing digestive problems, cognitive difficulties, emotional blunting, or financial strain, yet feeling unable to stop
- Using codeine to start the day: Taking codeine first thing in the morning to prevent withdrawal symptoms or to achieve a functional baseline before engaging with daily responsibilities
- Escalating doses over time: Taking progressively larger quantities to achieve the same effect, reflecting the development of tolerance
- Chronic constipation: Persistent bowel disruption that does not respond to dietary changes or over-the-counter remedies
- Recurring nausea and abdominal discomfort: Particularly on an empty stomach or at higher doses
- Frequent headaches: Particularly if codeine is used primarily for headache management; medication overuse headache creates a cycle of worsening headache frequency that codeine temporarily relieves but ultimately perpetuates
- Cognitive fog and poor concentration: Difficulty with memory, sustained attention, and mental clarity, often attributed to tiredness or stress
- Poor sleep quality: Fatigue despite sleeping, reduced REM sleep, and disturbing dreams (particularly evident when doses are missed)
- Withdrawal symptoms between doses: Restlessness, irritability, muscle aches, sweating, runny nose, and yawning appearing predictably when codeine is delayed or missed, and resolving promptly on taking the next dose
- Pallor, fatigue, and generalised physical decline: Reflecting the combined impact of nutritional neglect, sleep disruption, and the metabolic burden of chronic opioid and analgesic use
Mental Health and Codeine Addiction
The mental health dimensions of codeine addiction are as significant as the physical, and are frequently the aspect of dependence that is slowest to be recognised and addressed. The relationship between codeine use and mental health is bidirectional: pre-existing mental health difficulties are among the strongest risk factors for codeine dependence, and codeine dependence reliably worsens every aspect of mental health over time.
The Emotional Relief Trap
One of the most clinically important and practically underrecognised features of codeine addiction is the role of emotional relief in its development and maintenance. Codeine produces a state of warmth, calm, and emotional comfort that goes far beyond pain relief. For individuals experiencing untreated anxiety, depression, loneliness, occupational stress, grief, or the psychological burden of chronic illness, this emotional relief can feel revelatory. Codeine becomes not a pain medication but a coping mechanism.
The problem is that this effectiveness is temporary, self-defeating, and progressively destructive. With neuroadaptation, the emotional relief diminishes while the physical and psychological dependence deepens. The individual is left taking larger and larger quantities of codeine not to feel good but simply to avoid the profoundly uncomfortable baseline that dependence has created. Without addressing the underlying emotional distress that drove use in the first place, recovery from codeine addiction is significantly less likely to be sustained.
Common co-occurring mental health conditions of codeine misuse are:
Short and Long-Term Health Consequences
Short-Term Effects of Codeine Use
- Analgesia
- Mild euphoria, emotional warmth, and anxiolysis
- Sedation and reduced alertness
- Nausea and vomiting
- Constipation (virtually universal with regular use)
- Anterograde amnesia and cognitive impairment at higher doses
- Respiratory depression
Long-Term Health Consequences of Codeine Dependence
- Opioid-induced hyperalgesia
- Medication overuse headache
- Chronic constipation and bowel complications: haemorrhoids, fissures, impaction
- Liver damage
- Renal impairment
- Gastrointestinal ulceration and bleeding
- Persistent cognitive impairment: memory, concentration, and processing speed
- Hormonal disruption: reduced libido, menstrual irregularities, bone density loss
- Sleep architecture disruption and chronic fatigue
- Depression, anhedonia, and emotional blunting
- Social and occupational deterioration: relationship damage, reduced work performance, financial impact of maintaining supply
Recovery and Support at Banbury Lodge
Even after long periods of dependence on prescription or over-the-counter products, codeine addiction is treatable. With the right support, the brain and body can heal, withdrawal can be safely managed, and the underlying emotional or physical drivers of use can be properly addressed rather than masked.
At Banbury Lodge, treatment combines medical detoxification, structured psychological therapy, and specialist support for issues such as chronic pain, anxiety, and shame that often sit at the heart of codeine dependence. Care continues beyond detox through comprehensive aftercare, helping you maintain stability, manage triggers, and rebuild confidence in everyday life.
No one should have to navigate this alone, and waiting rarely makes things easier. If codeine has taken hold, reaching out now is a decisive first step toward breaking the cycle and starting again with the right support. Contact Banbury Lodge today.
Frequently asked questions
Codeine abuse can also cause other health problems such as liver damage, seizures and heart problems that can be life-threatening if left untreated. Additionally, codeine addiction can lead to risky behaviour, such as driving while under the influence, which can result in fatal accidents.
(Click here to see works cited)
- NHS (2024). Codeine: uses, side effects and addiction. NHS.uk.
- Medicines and Healthcare products Regulatory Agency (MHRA) (2023). Codeine: changes to pharmacy supply for pain relief. MHRA.
- Nielsen, S. et al. (2010). The extent and nature of codeine-containing medicines misuse and dependence in Australia. Pharmacoepidemiology and Drug Safety, 19(3), 280–288.
- Lembke, A. (2012). Why doctors prescribe opioids to known opioid abusers. New England Journal of Medicine, 367(17), 1580–1581.
- Manchikanti, L. et al. (2012). Opioid epidemic in the United States. Pain Physician, 15(3 Suppl), ES9–38.
- National Institute on Drug Abuse (NIDA) (2021). Prescription Opioids Research Report. U.S. Department of Health and Human Services.
- Headache UK / NICE (2021). Medication overuse headache — diagnosis and management. NICE guideline NG193.
- Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363–371.
- NICE (2021). Drug misuse in over 16s: opioid detoxification (CG52). National Institute for Health and Care Excellence.
- NHS (2024). Getting help for drug addiction. NHS.uk.
